You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 116 No. 11, November 1998 TABLE OF CONTENTS
  Archives
  •  Online Features
  Controversies
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (17)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Radiation Therapy
 •Choroidal Neovascularization
 •Macular Degeneration
 •Retinal/ Chorioretinal Disorders
 •Alert me on articles by topic

Radiotherapy and the Treatment of Age-related Macular Degeneration

External Beam Radiation Therapy Is Effective in the Treatment of Age-related Macular Degeneration

Arch Ophthalmol. 1998;116:1507-1509.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

NEOVASCULAR age-related macular degeneration (ARMD) is the leading cause of irreversible blindness in the western world. The only proven treatment involves laser photocoagulation of the abnormal and leaking subretinal vessels associated with neovascular ARMD. This is because several phase 3 efficacy trials have proved that laser photocoagulation of subretinal neovascular membranes in extrafoveal and subfoveal locations was associated with better visual acuity measurements compared with no treatment.1-2 Unfortunately, laser photocoagulation of subfoveal neovascularization induces an immediate central scotoma that is poorly tolerated by most patients, and only 10% to 15% of eyes with neovascular ARMD meet the criteria for laser treatment. Then, despite initial laser photocoagulation of the choroidal neovascularization (CNV), recurrent CNV (which usually affects the fovea and vision) develops in most patients. Since the majority of patients with neovascular ARMD become legally blind despite laser treatment, it is clear that we must investigate new therapies for neovascular ARMD.

. . . [Full Text of this Article]

WHAT IS THE RATIONALE FOR THE USE OF RADIATION THERAPY?


EVIDENCE THAT RADIATION THERAPY CAN AFFECT SUBRETINAL CNV AND SUBSEQUENT SCAR FORMATION

THE NEXT STEP?

RELATED ARTICLE

External Beam Radiation Therapy Is Not Effective in the Treatment of Age-related Macular Degeneration
James J. Augsburger
Arch Ophthalmol. 1998;116(11):1509-1511.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Palladium-103 plaque radiation therapy for macular degeneration: results of a 7 year study
Finger et al.
Br. J. Ophthalmol. 2003;87:1497-1503.
ABSTRACT | FULL TEXT  

Histopathological Changes Following Photodynamic Therapy in Human Eyes
Schmidt-Erfurth et al.
Arch Ophthalmol 2002;120:835-844.
FULL TEXT  

Computer-Assisted Quantitation of Choroidal Neovascularization for Clinical Trials
Berger and Yoken
IOVS 2000;41:2286-2295.
ABSTRACT | FULL TEXT  

Foveal relocation by redistribution of the neurosensory retina
Wong and Lois
Br. J. Ophthalmol. 2000;84:352-357.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.